巴基斯坦康希诺三期的数据预计在2月中旬出来,目前巴基斯坦已经将数据寄往加拿大进行分析。
消息来源:https://www.gwadarpro.pk/1354304810439372801/pakistanis-pin-their-hopes-on-cansino-biologics-vaccine
原文:Pakistan’s National Command and Operation Center (NCOC) announced the launch of phase-III clinical trials in the country for CanSino Vaccine in end-September 2020. Five different hospitals across the country, with the National Institute of Health (NIH) as principal investigator, initiated the trials with a sample size of 18,000.
Talking to China Economic Net (CEN), Dr. Ghazala Parveen, Chief of Biological Production Division NIH said, “So far, we have vaccinated 17,500 volunteers during a double-blind placebo control trial where 50% of people got the vaccine and 50 % got a placebo”. Placebo is a substance with no therapeutic value.
Dr Ghazala Parveen Chief of Biological Production Division NIH. [Photo/Tahir Ali]
According to her, the trial is moving towards successful completion; during the trial, no severe adverse events have been reported so far. Around 50% of the samples have been sent to Dalhousie University in Canada for analysis. “We are hopeful to get the complete analysis by mid-February,” she said.
精彩评论